Ginsenoside RG3 reduces lipid accumulation with AMP-activated protein kinase (AMPK) activation in HepG2 cells

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 5729-5739

  Lee, Seohyun ^a   Lee, Mak Soon ^a   Kim, Chong Tai ^b   Kim, In Hwan ^c   Kim, Yangha ^a  

^a Ewha Womans University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Korea University   (South Korea)

Author keywords

AMPK; Cardiovascular disease (CVD); Cholesterol; Ginsenoside Rg3; HMGCR; SREBP 2; Triglyceride

Indexed keywords

CHOLESTEROL; GINSENOSIDE RG 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; GINSENOSIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CELL LEVEL; CELL STRAIN HEPG2; CELL VIABILITY; CHOLESTEROL LIVER LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; ENZYME ACTIVATION; FATTY ACID HOMEOSTASIS; FOOD COMPOSITION; GENE EXPRESSION REGULATION; GENE REPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID STORAGE; LIVER METABOLISM; METABOLIC REGULATION; PROTEIN EXPRESSION; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; CHEMISTRY; DRUG EFFECTS; HEPG2 CELL LINE; LIPID METABOLISM; LIVER; METABOLISM; PANAX;

PANAX GINSENG;

AMP-ACTIVATED PROTEIN KINASES; ENZYME ACTIVATION; GINSENOSIDES; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIVER; PANAX;

EID: 84861548814     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13055729     Document Type: Article

References (27)

1. Deaton, C.; Froelicher, E.S.; Wu, L.H.; Ho, C.; Shishani, K.; Jaarsma, T. The global burden of cardiovascular disease. J. Cardiovasc Nurs. 2011, 26, S5-S14.
2. World Health Organization (WHO). Cardiovascular Diseases, 2011. Available online: http://www.who.int/mediacentre/factsheets/fs317/en/index.html (accessed on 1 February 2012).
3. Lü, J.-M.; Yao, Q.; Chen, C. Ginseng compounds: An update on their molecular mechanisms and medical applications. Curr. Vasc. Parmacol. 2009, 7, 293-302.
4. Hwang, J.-T.; Lee, M.-S.; Kim, H.-J.; Sung, M.-J.; Kim, H.Y.; Kim, M.S.; Kwon, D.Y. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-γ signal pathways. Phytother. Res. 2009, 23, 262-266.
5. Yeo, C.; Lee, S.; Popovich, D.G. Ginseng (Panax quinquefolius) reduces cell growth, lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Evid.-Based Complement. Alternat. Med. 2011, 2011, 610625-610633.
6. Park, M.W.; Ha, J.; Chung, S.H. 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK. Biol. Pharm. Bull. 2008, 31, 748-751.
7. Lee, J.-Y.; Lim, K.-M.; Kim, S.-Y.; Bea, O.-N.; Noh, J.-Y.; Chung, S.-M.; Kim, K.; Shin, Y.-S.; Lee, M.-Y.; Chung, J.-H. Vascular smooth muscle dysfunction and remodeling induced by ginsenoside Rg3, a bioactive component of ginseng. Toxicol. Sci. 2010, 117, 505-514.
8. Lim, S.; Yoon, J.W.; Choi, S.H.; Cho, B.J.; Kim, J.T.; Chang, H.S.; Park, H.S.; Park, K.S.; Lee, H.K.; Kim Y.-B.; et al. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism 2009, 58, 8-15.
9. Kim, S.N.; Lee, J.H.; Shin, H.; Son, S.H.; Kim, Y.S. Effects of in vitro-digested ginsenosides on lipid accumulation in 3T3-L1 adipocytes. Planta Med. 2009, 75, 596-601.
10. Brown, M.S.; Goldstein, J.L. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89, 331-340.
11. Kang, Q.; Chen, A. Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br. J. Pharmacol. 2009, 157, 1354-1367.
12. Carling, D.; Mayer, F.V.; Sanders, M.J.; Gamblin, S.J. AMP-activated protein kinase: Nature's energy sensor. Nat. Chem. Biol. 2011, 18, 512-518.
13. Zang, M.; Zuccollo, A.; Hou, X.; Nagate, D.; Walsh, K.; Herscovitz, H.; Brecher, P.; Ruderman, N.B.; Cohen, R.A. AMP-activated protein kinase is required for the lipid-lowering effect of Metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 2004, 279, 47898-47905.
14. Steinberg, G.R.; Kemp, B.E. AMPK in health and disease. Physiol. Rev. 2009, 89, 1025-1078.
15. Park, I.H.; Piao, L.Z.; Kwon, S.W.; Lee, Y.J.; Cho, S.Y.; Park, M.K.; Park, J.H. Cytotoxic dammarane glycosides from processed ginseng. Chem. Pharm. Bull. 2002, 50, 538-540.
16. Huang, J.; Tang, X.-H.; Ikejima, T.; Sun, X.-J.; Wang, X.-B.; Xi, R.-G.; Wu, L.-J. A new triterpenoid from Panax ginseng exhibits cytotoxicity through p53 and the caspase signaling pathway in the HepG2 cell line. Arch. Pharm. Res. 2008, 31, 323-329.
17. Jiang, J.-W.; Chen, X.-M.; Chen, X.-H.; Zhang, S.-S. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J. Gastroenterol. 2011, 17, 3605-3613.
18. Kang, K.S.; Yamabe, N.; Kim, H.Y.; Park, J.H.; Yokozawa, T. Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats. Biol. Pharm. Bull. 2010, 33, 1077-1081.
19. Song, T.-B.; An, Y.R.; Kim, S.J.; Park, H.-W.; Jung, J.-W.; Kyung, J.-S.; Hwang, S.Y.; Kim, Y.-S. Lipid metabolic effect of Korean red ginseng extract in mice fed on a high-fat diet. J. Sci. Food Agric. 2012, 92, 388-396.
20. Horton, J.D.; Goldstein, J.L.; Brown, M.S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109, 1125-1131.
21. Horton, J.D.; Shimomura, I.; Brown, M.S.; Hammer, R.E.; Goldstein, J.L.; Shimano, H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 1998, 101, 2331-2339.
22. Matsda, M.; Korn, B.S.; Hammer, R.E.; Moon, Y.-A.; Komuro, R.; Horton, J.D.; Goldstein, J.L.; Brown, M.S.; Shimomura, I. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 2001, 15, 1206-1216.
23. Chen, Q.; Reimer, R.A. Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 2009, 25, 340-349.
24. Viollet, B.; Guigas, B.; Leclerc, J.; Hébrard, S.; Lantier, L.; Mounier, R.; Andreelli, F.; Foretz, M. AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives. Acta Physiol. 2009, 196, 81-98.
25. Li, Y.; Xu, S.; Mihaylova, M.M.; Zheng, B.; Hou, X.; Jiang, B.; Park, O.; Luo, Z.; Lefai, E.; Shyy, J.Y.-J.; et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011, 13, 376-388.
26. Rozen, S.; Skaletsky, H.J. Primer3 on the www for General Users and for Biologist Programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology; Krawetz, S., Misener, S., Eds.; Humana Press: Totowa, NJ, USA, 1999; Volume 132, pp. 365-386.
27. -ΔΔCt method. Methods 2001, 25, 402-408.